Lv61
2590 积分 2024-04-13 加入
α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation
23天前
已完结
Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor
23天前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
27天前
已完结
Molecular glue-based RAS-MAPK targeting
27天前
已完结
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers
30天前
已完结
Discovery and Characterization of RP03707: A Highly Potent and Selective KRASG12D PROTAC
1个月前
已完结
Targeting cancer with small-molecule pan-KRAS degraders
1个月前
已关闭
Translating ferroptosis into oncology: challenges, opportunities and future directions
1个月前
已关闭
CDK4/6 inhibition provides additional efficacy in HER2(+), HR(+) breast cancer
1个月前
已关闭
Cancer statistics, 2026: divergent trends and the implementation gap
1个月前
已完结
皖公网安备34019202002308
